Published in

Massachusetts Medical Society, New England Journal of Medicine, 8(389), p. 764-766, 2023

DOI: 10.1056/nejmc2306105

Links

Tools

Export citation

Search in Google Scholar

Cell-of-Origin Subtypes and Therapeutic Benefit from Polatuzumab Vedotin

Journal article published in 2023 by Adam C. Palmer, David M. Kurtz ORCID, Ash A. Alizadeh ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO